Skip to Content

FDA Informs Eisai Medical Research on 'Misleading' Aricept TV Ads

ROCKVILLE, Md., Feb. 18, 2010--The FDA has posted on its website a letter regarding two television ads for the Alzheimer’s disease drug Aricept. The agency said the ads are misleading because they overstate the drug's efficiacy.

Posted: February 2010

Recommended for you